ID-EPTRI: a new research infrastructure for better paediatric medicines emerges

Published 2 February 2018

Did you know that it is estimated that 50% of the medicines addressed to children and young patients have not been tested specifically for them?

Children and young patients should not be compared with their adult counterparts while they are growing because their metabolism is different. The only real way to develop better medicines for children and young patients is to engineer studies and solutions specifically for this type of “special” population. Currently there is a need to find answers to the serious lack of medicines for children in Europe and around the world. The development of evidence-based paediatric medicines and treatment strategies, is essential.

That is why the European Paediatric Translational Research Infrastructure (ID-EPTRI) has been established. It is a new research infrastructure that will facilitate the future development of better paediatric medicines.

The ID-EPTRI project, funded within the H2020-INFRADEV-01-2017 programme and coordinated by CVBF, aims to design the framework for a new Research Infrastructure (RI) intended to enhance paediatric research in all phases of the drug development pipeline, resulting in more informed paediatric use of medicines.

The project will also propose development models for paediatric medicines that integrates technology-driven aspects with clinical trials.

EPTRI is a welcome addition to the existing RIs filling the current gaps in paediatric medicines, and will act as a ‘Paediatric Common Service’ in the ESFRI (European Strategy Forum on Research Infrastructures) Scenario. The project involves 26 partners from EU and non-EU countries including consolidated research infrastructures, top-level universities, scientific and clinical centers of excellence in Europe.

EATRIS is excited to join this consortium. Together with two other well-established RIs, BBMRI and ECRIN, we hope to harness efficiency in the delivery of paediatric research activities and services strengthening collaboration within the scientific paediatric community.

The project was recently kick-started in Rome on January 15th-16th and will last 24 months.

Additional information

To view press release, click here

For more information on the project, please visit the dedicated webpage at